Pharmacokinetic Interaction Study of Glycopyrrolate and Formoterol in Healthy Volunteers

Study Identifier:
CCD-1101-PR-0056
ClinicalTrials.gov Identifier:
NCT01398111
EudraCT Identifier:
2011-001552-11
EU CT ID:
N/A
Study Contact Information:
N/A
Study Complete

Trial Documents

Clinical Study Report
Available Languages: English
Download document(s)

Study Details

Medical Condition
  • Chronic Obstructive Pulmonary Disease
Study Drug
  • Drug: Glycopyrrolate + Formoterol
  • Drug: Glycopyrrolate
  • Drug: Formoterol
  • Drug: Placebo
Date
May 2011 - Aug 2011
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 65 Years
Requirements Information
Inclusion and Exclusion Criteria
Inclusion Criteria
  • Inclusion Criteria:
  • Males and females healthy volunteers aged 18-65 years will be included in the study.
Healthy Volunteers
Yes

Protocol Summary

This study will be carried out in healthy volunteers with the primary objective to evaluate the pharmacokinetic interaction between Glyco and Formoterol administered using a pressurised metered dose inhaler (pMDI).

Study Locations

Location
Status
Location
Clinical Pharmacology Unit - SGS Life Science Services
Antwerp, Lange Beeldekensstraat 267, Belgium, 2060
Status
N/A